Open AccessA study on clinico-pathological assessment of response to neoadjuvant chemotherapy in breast carcinoma
Author(s) -
Manisha Mohapatra,
Yerraguntla Subramanya Sarma
Publication year - 2020
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_295_19
Subject(s) - medicine , lumpectomy , breast cancer , breast carcinoma , chemotherapy , oncology , pathological , grading (engineering) , cyclophosphamide , biopsy , neoadjuvant therapy , estrogen receptor , pathology , mastectomy , cancer , civil engineering , engineering
Neoadjuvant chemotherapy (NACT) has become a strategy in the multidisciplinary treatment approach to breast cancer. Since clinical and radiological responses do not correlate well with residual tumor after treatment, pathological evaluation of tumor response to chemotherapy is essential for accurate assessment.